Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$110.45 USD
+0.42 (0.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $110.46 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: AMC |
9/2024 | $5.47 | -1.63% |
Earnings Summary
For their last quarter, Jazz Pharmaceuticals (JAZZ) reported earnings of $5.30 per share, beating the Zacks Consensus Estimate of $4.68 per share. This reflects a positive earnings surprise of 13.25%. Look out for JAZZ's next earnings release on November 06, 2024. For the next earning release, we expect the company to report earnings of $5.47 per share, reflecting a year-over-year increase of 13.02%.
Earnings History
Price & Consensus
Zacks News for JAZZ
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services